Business

January 24, 2014

BioDelivery Sciences stock surges after positive drug trial results

BioDelivery Sciences International stock jumped 51 percent Friday after the Raleigh company reported positive clinical trial results for its experimental treatment for chronic pain.

Related content

Comments

Videos

Editor's Choice Videos